981 related articles for article (PubMed ID: 10352397)
1. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
2. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
3. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
Snyder DK; Clemmons DR; Underwood LE
J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.
Clemmons DR; Snyder DK; Williams R; Underwood LE
J Clin Endocrinol Metab; 1987 May; 64(5):878-83. PubMed ID: 3558728
[TBL] [Abstract][Full Text] [Related]
5. Persistent lipolytic effect of exogenous growth hormone during caloric restriction.
Snyder DK; Underwood LE; Clemmons DR
Am J Med; 1995 Feb; 98(2):129-34. PubMed ID: 7847429
[TBL] [Abstract][Full Text] [Related]
6. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.
Snyder DK; Clemmons DR; Underwood LE
J Clin Endocrinol Metab; 1989 Oct; 69(4):745-52. PubMed ID: 2778033
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
Tagliaferri M; Scacchi M; Pincelli AI; Berselli ME; Silvestri P; Montesano A; Ortolani S; Dubini A; Cavagnini F
Int J Obes Relat Metab Disord; 1998 Sep; 22(9):836-41. PubMed ID: 9756240
[TBL] [Abstract][Full Text] [Related]
8. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent.
Snyder DK; Underwood LE; Clemmons DR
Am J Clin Nutr; 1990 Sep; 52(3):431-7. PubMed ID: 2203249
[TBL] [Abstract][Full Text] [Related]
9. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
[TBL] [Abstract][Full Text] [Related]
10. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone.
Ellis KJ; Lee PD; Pivarnik JM; Bukar JG; Gesundheit N
J Clin Endocrinol Metab; 1996 Aug; 81(8):3033-8. PubMed ID: 8768870
[TBL] [Abstract][Full Text] [Related]
11. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone in obesity.
Scacchi M; Pincelli AI; Cavagnini F
Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
[TBL] [Abstract][Full Text] [Related]
13. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.
Nørrelund H; Vahl N; Juul A; Møller N; Alberti KG; Skakkebaek NE; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2000 May; 85(5):1912-7. PubMed ID: 10843174
[TBL] [Abstract][Full Text] [Related]
14. Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity.
Pasarica M; Zachwieja JJ; Dejonge L; Redman S; Smith SR
J Clin Endocrinol Metab; 2007 Nov; 92(11):4265-70. PubMed ID: 17785361
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
16. Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects.
Rasmussen MH; Juul A; Kjems LL; Hilsted J
Eur J Endocrinol; 2006 Oct; 155(4):575-81. PubMed ID: 16990657
[TBL] [Abstract][Full Text] [Related]
17. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
[TBL] [Abstract][Full Text] [Related]
18. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects.
Drent ML; Wever LD; Adèr HJ; van der Veen EA
Eur J Endocrinol; 1995 May; 132(5):565-72. PubMed ID: 7538403
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
